Ghrelin in psychiatric disorders - A review

Psychoneuroendocrinology

Volumn 52, Issue 1, 2015, Pages 176-194

  Wittekind, Dirk Alexander ^a   Kluge, Michael ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Addiction; Alzheimer; Depression; Eating disorder; Ghrelin; Psychiatry

Indexed keywords

GHRELIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE;

ADDICTION; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANOREXIA NERVOSA; ANTIDEPRESSANT ACTIVITY; ANXIETY; ANXIETY DISORDER; ARTICLE; BINGE EATING DISORDER; BULIMIA; DEGENERATIVE DISEASE; DEMENTIA; DEPRESSION; DRUG SEEKING BEHAVIOR; EATING DISORDER; GENETIC ASSOCIATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INSOMNIA; MENTAL DISEASE; MOOD DISORDER; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SCHIZOPHRENIA; SMOKING; STRESS; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; GHRELIN; HUMANS; MENTAL DISORDERS;

EID: 84922641385     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.11.013     Document Type: Review

References (243)

1. Abizaid A., Liu Z., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., Roth R.H., Sleeman M.W., Picciotto M.R., Tschöp M.H., Gao X., Horvath T.L. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 2006, 116:3229-3239.10.1172/JCI29867.In.
2. Addolorato G., Capristo E., Leggio L., Ferrulli A., Abenavoli L., Malandrino N., Farnetti S., Domenicali M., D'Angelo C., Vonghia L., Mirijello A., Cardone S., Gasbarrini G. Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. Alcohol. Clin. Exp. Res. 2006, 30:1933-1937.10.1111/j.1530-0277.2006.00238.x.
3. al'Absi M., Lemieux A., Nakajima M. Peptide YY and ghrelin predict craving and risk for relapse in abstinent smokers. Psychoneuroendocrinology 2014, 49C:253-259.10.1016/j.psyneuen.2014.07.018.
4. Alvarez-Crespo M., Skibicka K.P., Farkas I., Molnár C.S., Egecioglu E., Hrabovszky E., Liposits Z., Dickson S.L. The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence. PLOS ONE 2012, 7:e46321.10.1371/journal.pone.0046321.
5. Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, American Psychiatric Publishing, Arlington, VA. 5th ed.
6. Ando T. Ghrelin gene variants and eating disorders. Vitam. Horm. 2013, 92:107-123.10.1016/B978-0-12-410473-0.00004-0.
7. Ando T., Komaki G., Naruo T., Okabe K., Takii M., Kawai K., Konjiki F., Takei M., Oka T., Takeuchi K., Masuda A., Ozaki N., Suematsu H., Denda K., Kurokawa N., Itakura K., Yamaguchi C., Kono M., Suzuki T., Nakai Y., Nishizono-Maher A., Koide M., Murakami K., Nagamine K., Tomita Y., Ookuma K., Tomita K., Tonai E., Ooshima A., Ishikawa T., Ichimaru Y. Possible role of preproghrelin gene polymorphisms in susceptibility to bulimia nervosa. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2006, 141B:929-934.10.1002/ajmg.b.30387.
8. Andrews Z.B. The extra-hypothalamic actions of ghrelin on neuronal function. Trends Neurosci. 2011, 34:31-40.10.1016/j.tins.2010.10.001.
9. Andrews Z.B., Erion D., Beiler R., Liu Z.-W., Abizaid A., Zigman J., Elsworth J.D., Savitt J.M., DiMarchi R., Tschop M., Roth R.H., Gao X.-B., Horvath T.L. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J. Neurosci. 2009, 29:14057-14065.10.1523/JNEUROSCI.3890-09.2009.
10. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Fujimiya M., Katsuura G., Makino S., Fujino M.A., Kasuga M. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001, 74:143-147.
11. Atalayer D., Gibson C., Konopacka A., Geliebter A. Ghrelin and eating disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 40:70-82.10.1016/j.pnpbp.2012.08.011.
12. Atcha Z., Chen W.-S., Ong A.B., Wong F.-K., Neo A., Browne E.R., Witherington J., Pemberton D.J. Cognitive enhancing effects of ghrelin receptor agonists. Psychopharmacology (Berl). 2009, 206:415-427.10.1007/s00213-009-1620-6.
13. Badaoui A., De Saeger C., Duchemin J., Gihousse D., de Timary P., Stärkel P. Alcohol dependence is associated with reduced plasma and fundic ghrelin levels. Eur. J. Clin. Invest. 2008, 38:397-403.10.1111/j.1365-2362.2008.01947.x.
14. Bahi A., Tolle V., Fehrentz J.-A., Brunel L., Martinez J., Tomasetto C.-L., Karam S.M. Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference. Peptides 2013, 43:48-55.10.1016/j.peptides.2013.02.008.
15. Banks W.A. The blood-brain barrier: connecting the gut and the brain. Regul. Pept. 2008, 149:11-14.10.1016/j.regpep.2007.08.027.
16. Banks W.A., Tschöp M., Robinson S.M., Heiman M.L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J. Pharmacol. Exp. Ther. 2002, 302:822-827.10.1124/jpet.102.034827.
17. Barim A.O., Aydin S., Colak R., Dag E., Deniz O., Sahin I. Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment. Clin. Biochem. 2009, 42:1076-1081.10.1016/j.clinbiochem.2009.02.020.
18. Bayliss J.A., Andrews Z.B. Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection. Ther. Adv. Endocrinol. Metab. 2013, 4:25-36.10.1177/2042018813479645.
19. Bellar D., Glickman E.L., Judge L.W., Gunstad J. Serum ghrelin is associated with verbal learning and adiposity in a sample of healthy, fit older adults. Biomed. Res. Int. 2013, 2013:202757.10.1155/2013/202757.
20. Birkás Kováts D., Palik E., Faludi G., Cseh K. Possible connection between ghrelin, resistin and TNF-alpha levels and the metabolic syndrome caused by atypical antipsychotics. Neuropsychopharmacol. Hung. 2005, 7:132-139.
21. Bowers M.E., Choi D.C., Ressler K.J. Neuropeptide regulation of fear and anxiety: implications of cholecystokinin, endogenous opioids, and neuropeptide Y. Physiol. Behav. 2012, 107:699-710.10.1016/j.physbeh.2012.03.004.
22. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
23. Bruder E.D., Jacobson L., Raff H. Plasma leptin and ghrelin in the neonatal rat: interaction of dexamethasone and hypoxia. J. Endocrinol. 2005, 185:477-484.10.1677/joe.1.06159.
24. Cabral A., Suescun O., Zigman J.M., Perello M. Ghrelin indirectly activates hypophysiotropic CRF neurons in rodents. PLOS ONE 2012, 7:e31462.10.1371/journal.pone.0031462.
25. Calissendorff J., Danielsson O., Brismar K., Röjdmark S. Inhibitory effect of alcohol on ghrelin secretion in normal man. Eur. J. Endocrinol. 2005, 152:743-747.10.1530/eje.1.01905.
26. Calissendorff J., Danielsson O., Brismar K., Röjdmark S. Alcohol ingestion does not affect serum levels of peptide YY but decreases both total and octanoylated ghrelin levels in healthy subjects. Metabolism 2006, 55:1625-1629.10.1016/j.metabol.2006.08.003.
27. Carlini V.P., Machado D.G., Buteler F., Ghersi M., Ponzio M.F., Martini A.C., Schiöth H.B., de Cuneo M.F., Rodrigues A.L.S., de Barioglio S.R. Acute ghrelin administration reverses depressive-like behavior induced by bilateral olfactory bulbectomy in mice. Peptides 2012, 35:160-165.10.1016/j.peptides.2012.03.031.
28. Carlini V.P., Monzón M.E., Varas M.M., Cragnolini A.B., Schiöth H.B., Scimonelli T.N., De Barioglio S.R. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem. Biophys. Res. Commun. 2002, 299:739-743.
29. Carlini V.P., Varas M.M., Cragnolini A.B., Schiöth H.B., Scimonelli T.N., De Barioglio S.R. Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem. Biophys. Res. Commun. 2004, 313:635-641.10.1016/j.bbrc.2003.11.150.
30. Cellini E., Nacmias B., Brecelj-Anderluh M., Badía-Casanovas A., Bellodi L., Boni C., Di Bella D., Estivill X., Fernandez-Aranda F., Foulon C., Friedel S., Gabrovsek M., Gorwood P., Gratacos M., Guelfi J., Hebebrand J., Hinney A., Holliday J., Hu X., Karwautz A., Kipman A., Komel R., Rotella C.M., Ribases M., Ricca V., Romo L., Tomori M., Treasure J., Wagner G., Collier D.A., Sorbi S. Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. Psychiatr. Genet. 2006, 16:51-52.10.1097/01.ypg.0000194444.89436.e9.
31. Chen L., Xing T., Wang M., Miao Y., Tang M., Chen J., Li G., Ruan D.-Y. Local infusion of ghrelin enhanced hippocampal synaptic plasticity and spatial memory through activation of phosphoinositide 3-kinase in the dentate gyrus of adult rats. Eur. J. Neurosci. 2011, 33:266-275.10.1111/j.1460-9568.2010.07491.x.
32. Chuang J.-C., Perello M., Sakata I., Osborne-Lawrence S., Savitt J.M., Lutter M., Zigman J.M. Ghrelin mediates stress-induced food-reward behavior in mice. J. Clin. Invest. 2011, 121:2684-2692.10.1172/JCI57660.
33. Chuang J.-C., Zigman J.M. Ghrelin's roles in stress, mood, and anxiety regulation. Int. J. Pept. 2010,10.1155/2010/460549.
34. Chung H., Seo S., Moon M., Park S. Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J. Endocrinol. 2008, 198:511-521.10.1677/JOE-08-0160.
35. Cone J.J., Mccutcheon J.E., Roitman M.F. Ghrelin acts as an interface between physiological state and phasic dopamine signaling. J. Neurosci. 2014, 34:4905-4913.10.1523/JNEUROSCI.4404-13.2014.
36. Cruz M.T., Herman M.A., Cote D.M., Ryabinin A.E., Roberto M. Ghrelin increases GABAergic transmission and interacts with ethanol actions in the rat central nucleus of the amygdala. Neuropsychopharmacology 2013, 38:364-375.10.1038/npp.2012.190.
37. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50:1714-1719.
38. Currie P.J., Khelemsky R., Rigsbee E.M., Dono L.M., Coiro C.D., Chapman C.D., Hinchcliff K. Ghrelin is an orexigenic peptide and elicits anxiety-like behaviors following administration into discrete regions of the hypothalamus. Behav. Brain Res. 2012, 226:96-105.10.1016/j.bbr.2011.08.037.
39. Currie P.J., Schuette L.M., Wauson S.E.R., Voss W.N., Angeles M.J. Activation of urocortin 1 and ghrelin signaling in the basolateral amygdala induces anxiogenesis. Neuroreport 2014, 25:60-64.10.1097/WNR.0000000000000047.
40. Dardennes R.M., Zizzari P., Tolle V., Foulon C., Kipman A., Romo L., Iancu-Gontard D., Boni C., Sinet P.-M., Thérèse Bluet M., Estour B., Mouren M.-C., Guelfi J.-D., Rouillon F., Gorwood P., Epelbaum J. Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with Anorexia nervosa: association with subtype, body-mass index, severity and age of onset. Psychoneuroendocrinology 2007, 32:106-113.10.1016/j.psyneuen.2006.11.003.
41. Date Y., Shimbara T., Koda S., Toshinai K., Ida T., Murakami N., Miyazato M., Kokame K., Ishizuka Y., Ishida Y., Kageyama H., Shioda S., Kangawa K., Nakazato M. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell Metab. 2006, 4:323-331.10.1016/j.cmet.2006.09.004.
42. Davis J.F., Choi D.L., Clegg D.J., Benoit S.C. Signaling through the ghrelin receptor modulates hippocampal function and meal anticipation in mice. Physiol. Behav. 2011, 103:39-43.10.1016/j.physbeh.2010.10.017.
43. Davis M.E., Pemberton C.J., Yandle T.G., Lainchbury J.G., Rademaker M.T., Nicholls M.G., Frampton C.M., Richards A.M. Urocortin-1 infusion in normal humans. J. Clin. Endocrinol. Metab. 2004, 89:1402-1409.10.1210/jc.2003-031231.
44. Delhanty P.J.D., Neggers S.J., van der Lely A.J. Should we consider des-acyl ghrelin as a separate hormone and if so, what does it do?. Front. Horm. Res. 2014, 42:163-174.10.1159/000358345.
45. Dezaki K. Ghrelin function in insulin release and glucose metabolism. Endocr. Dev. 2013, 25:135-143.10.1159/000346064.
46. Dhurandhar E.J., Allison D.B., van Groen T., Kadish I. Hunger in the absence of caloric restriction improves cognition and attenuates Alzheimer's disease pathology in a mouse model. PLOS ONE 2013, 8:e60437.10.1371/journal.pone.0060437.
47. Diano S., Farr S.A., Benoit S.C., McNay E.C., da Silva I., Horvath B., Gaskin F.S., Nonaka N., Jaeger L.B., Banks W.A., Morley J.E., Pinto S., Sherwin R.S., Xu L., Yamada K.A., Sleeman M.W., Tschöp M.H., Horvath T.L. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 2006, 9:381-388.10.1038/nn1656.
48. Dickson S.L., Egecioglu E., Landgren S., Skibicka K.P., Engel J.A., Jerlhag E. Molecular and cellular endocrinology: the role of the central ghrelin system in reward from food and chemical drugs. Mol. Cell. Endocrinol. 2011, 340:80-87.10.1016/j.mce.2011.02.017.
49. Dos Santos V.V., Rodrigues A.L.S., De Lima T.C., de Barioglio S.R., Raisman-Vozari R., Prediger R.D. Ghrelin as a neuroprotective and palliative agent in Alzheimer's and Parkinson's disease. Curr. Pharm. Des. 2013, 19:6773-6790.
50. Dresler M., Kluge M., Genzel L., Schüssler P., Steiger A. Nocturnal administration of ghrelin does not promote memory consolidation. Pharmacopsychiatry 2010, 43:277-278.10.1055/s-0030-1263175.
51. Dzaja A., Dalal M.A., Himmerich H., Uhr M., Pollmächer T., Schuld A. Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E963-E967.10.1152/ajpendo.00527.2003.
52. Egecioglu E., Jerlhag E., Salomé N., Skibicka K.P., Haage D., Bohlooly-Y M., Andersson D., Bjursell M., Perrissoud D., Engel J.A., Dickson S.L. Ghrelin increases intake of rewarding food in rodents. Addict. Biol. 2010, 15:304-311.10.1111/j.1369-1600.2010.00216.x.
53. Emanuel A.J., Ritter S. Hindbrain catecholamine neurons modulate the growth hormone but not the feeding response to ghrelin. Endocrinology 2010, 151:3237-3246.10.1210/en.2010-0219.
54. Emül H.M., Serteser M., Kurt E., Ozbulut O., Guler O., Gecici O. Ghrelin and leptin levels in patients with obsessive-compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:1270-1274.10.1016/j.pnpbp.2007.05.007.
55. Esen-Danaci A., Sarandöl A., Taneli F., Yurtsever F., Ozlen N. Effects of second generation antipsychotics on leptin and ghrelin. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1434-1438.10.1016/j.pnpbp.2008.03.015.
56. Espelund U., Hansen T.K., Ørskov H., Frystyk J. Assessment of ghrelin. APMIS 2003, Suppl.:140-145.
57. Frago L.M., Baquedano E., Argente J., Chowen J. Neuroprotective actions of ghrelin and growth hormone secretagogues. Front. Mol. Neurosci. 2011, 4:23.10.3389/fnmol.2011.00023.
58. Frago L.M., Pañeda C., Dickson S.L., Hewson A.K., Argente J., Chowen J.A. Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 2002, 143:4113-4122.10.1210/en.2002-220261.
59. Furness J.B., Hunne B., Matsuda N., Yin L., Russo D., Kato I., Fujimiya M., Patterson M., McLeod J., Andrews Z.B., Bron R. Investigation of the presence of ghrelin in the central nervous system of the rat and mouse. Neuroscience 2011, 193:1-9.10.1016/j.neuroscience.2011.07.063.
60. Gahete M.D., Córdoba-Chacón J., Kineman R.D., Luque R.M., Castaño J.P. Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease. Peptides 2011, 32:2225-2228.10.1016/j.peptides.2011.09.019.
61. Gahete M.D., Rincón-Fernández D., Villa-Osaba A., Hormaechea-Agulla D., Ibáñez-Costa A., Martínez-Fuentes A.J., Gracia-Navarro F., Castaño J.P., Luque R.M. Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight. J. Endocrinol. 2014, 220:R1-R24.10.1530/JOE-13-0391.
62. Gahete M.D., Rubio A., Córdoba-Chacón J., Gracia-Navarro F., Kineman R.D., Avila J., Luque R.M., Castaño J.P. Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients. J. Alzheimers Dis. 2010, 22:819-828.10.3233/JAD-2010-100873.
63. Gardner A., Boles R.G. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:730-743.10.1016/j.pnpbp.2010.07.030.
64. Garin M.C., Burns C.M., Kaul S., Cappola A.R. Clinical review: the human experience with ghrelin administration. J. Clin. Endocrinol. Metab. 2013, 98:1826-1837.10.1210/jc.2012-4247.
65. Gecici O., Kuloglu M., Atmaca M., Tezcan A.E., Tunckol H., Emül H.M., Ustundag B. High serum leptin levels in depressive disorders with atypical features. Psychiatry Clin. Neurosci. 2005, 59:736-738.10.1111/j.1440-1819.2005.01445.x.
66. Geliebter A., Gluck M.E., Hashim S.A. Plasma ghrelin concentrations are lower in binge-eating disorder. J. Nutr. 2005, 135:1326-1330.
67. Germain N., Galusca B., Grouselle D., Frere D., Billard S., Epelbaum J., Estour B. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. J. Clin. Endocrinol. Metab. 2010, 95:3057-3062.10.1210/jc.2009-2196.
68. Ghavami S., Shojaei S., Yeganeh B., Ande S.R., Jangamreddy J.R., Mehrpour M., Christoffersson J., Chaabane W., Moghadam A.R., Kashani H.H., Hashemi M., Owji A.A., Łos M.J. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog. Neurobiol. 2014, 112:24-49.10.1016/j.pneurobio.2013.10.004.
69. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 2002, 87:2988.10.1210/jcem.87.6.8739.
70. Gomes S., Martins I., Fonseca A.C.R., Oliveira C.R., Resende R., Pereira C.M. Protective effect of leptin and ghrelin against toxicity induced by amyloid-β oligomers in a hypothalamic cell line. J. Neuroendocrinol. 2014,10.1111/jne.12138.
71. Grouselle D., Chaillou E., Caraty A., Bluet-Pajot M.-T., Zizzari P., Tillet Y., Epelbaum J. Pulsatile cerebrospinal fluid and plasma ghrelin in relation to growth hormone secretion and food intake in the sheep. J. Neuroendocrinol. 2008, 20:1138-1146.10.1111/j.1365-2826.2008.01770.x.
72. Gutierrez J.A., Solenberg P.J., Perkins D.R., Willency J.A., Knierman M.D., Jin Z., Witcher D.R., Luo S., Onyia J.E., Hale J.E. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6320-6325.10.1073/pnas.0800708105.
73. Hansson C., Alvarez-Crespo M., Taube M., Skibicka K.P., Schmidt L., Karlsson-Lindahl L., Egecioglu E., Nissbrandt H., Dickson S.L. Influence of ghrelin on the central serotonergic signaling system in mice. Neuropharmacology 2014, 79C:1-8.10.1016/j.neuropharm.2013.12.012.
74. Hansson C., Annerbrink K., Nilsson S., Bah J., Olsson M., Allgulander C., Andersch S., Sjödin I., Eriksson E., Dickson S.L. A possible association between panic disorder and a polymorphism in the preproghrelingene. Psychiatry Res. 2013, 206:22-25.10.1016/j.psychres.2012.09.051.
75. Hansson C., Haage D., Taube M., Egecioglu E., Salomé N., Dickson S.L. Central administration of ghrelin alters emotional responses in rats: behavioural, electrophysiological and molecular evidence. Neuroscience 2011, 180:201-211.10.1016/j.neuroscience.2011.02.002.
76. Himmerich H., Fulda S., Künzel H.E., Pfennig A., Dzaja A., Cummings D.E., Pollmächer T. Ghrelin plasma levels during psychopharmacological treatment. Neuropsychobiology 2005, 52:11-16.10.1159/000086171.
77. Homan P., Grob S., Milos G., Schnyder U., Hasler G. Reduction in total plasma ghrelin levels following catecholamine depletion: relation to bulimic and depressive symptoms. Psychoneuroendocrinology 2013, 38:1545-1552.10.1016/j.psyneuen.2012.12.024.
78. Hosojima H., Togo T., Odawara T., Hasegawa K., Miura S., Kato Y., Kanai A., Kase A., Uchikado H., Hirayasu Y. Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia. J. Psychopharmacol. 2006, 20:75-79.10.1177/0269881105056647.
79. Hotta M., Ohwada R., Akamizu T., Shibasaki T., Takano K., Kangawa K. Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocr. J. 2009, 56:1119-1128.
80. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., Chou M., Liu K.K., McKee K.K., Pong S.S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D.J., Dean D.C., Melillo D.G., Patchett A.A., Nargund R., Griffin P.R., DeMartino J.A., Gupta S.K., Schaeffer J.M., Smith R.G., Van der Ploeg L.H. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.10.1126/science.273.5277.974.
81. Hsu D.T., Kirouac G.J., Zubieta J.-K., Bhatnagar S. Contributions of the paraventricular thalamic nucleus in the regulation of stress, motivation, and mood. Front. Behav. Neurosci. 2014, 8:73.10.3389/fnbeh.2014.00073.
82. Hyytiä P., Koob G.F. GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur. J. Pharmacol. 1995, 283:151-159.
83. Ishitobi Y., Kohno K., Kanehisa M., Inoue A., Imanaga J., Maruyama Y., Ninomiya T., Higuma H., Okamoto S., Tanaka Y., Tsuru J., Hanada H., Isogawa K., Akiyoshi J. Serum ghrelin levels and the effects of antidepressants in major depressive disorder and panic disorder. Neuropsychobiology 2012, 66:185-192.10.1159/000339948.
84. Janas-Kozik M., Krupka-Matuszczyk I., Malinowska-Kolodziej I., Lewin-Kowalik J. Total ghrelin plasma level in patients with the restrictive type of anorexia nervosa. Regul. Pept. 2007, 140:43-46.10.1016/j.regpep.2006.11.005.
85. Jaremka L.M., Belury M.A., Andridge R.R., Malarkey W.B., Glaser R., Christian L., Emery C.F., Kiecolt-Glaser J.K. Interpersonal stressors predict ghrelin and leptin levels in women. Psychoneuroendocrinology 2014, 48C:178-188.10.1016/j.psyneuen.2014.06.018.
86. Jerlhag E. Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict. Biol. 2008, 13:358-363.10.1111/j.1369-1600.2008.00125.x.
87. Jerlhag E., Egecioglu E., Dickson S.L., Andersson M., Svensson L., Engel J.A. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict. Biol. 2006, 11:45-54.10.1111/j.1355-6215.2006.00002.x.
88. Jerlhag E., Egecioglu E., Dickson S.L., Douhan A., Svensson L., Engel J.A. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict. Biol. 2007, 12:6-16.10.1111/j.1369-1600.2006.00041.x.
89. Jerlhag E., Egecioglu E., Dickson S.L., Engel J.A. Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system. Addict. Biol. 2011, 16:82-91.10.1111/j.1369-1600.2010.00231.x.
90. Jerlhag E., Egecioglu E., Landgren S., Salomé N., Heilig M., Moechars D., Datta R., Perrissoud D., Dickson S.L., Engel J.A. Requirement of central ghrelin signaling for alcohol reward. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11318-11323.10.1073/pnas.0812809106.
91. Jerlhag E., Ivanoff L., Vater A. Peripherally circulating ghrelin does not mediate alcohol-induced reward and alcohol intake in rodents. Alcohol. Clin. Exp. Res. 2014, 38:959-968.10.1111/acer.12337.
92. Jerlhag E., Ivanoff L., Vater A., Engel J.A. Peripherally circulating ghrelin does not mediate alcohol-induced reward and alcohol intake in rodents. Alcohol. Clin. Exp. Res. 2014, 38:959-968.10.1111/acer.12337.
93. Jerlhag E., Janson A.C., Waters S., Engel J.A. Concomitant release of ventral tegmental acetylcholine and accumbal dopamine by ghrelin in rats. PLOS ONE 2012, 7:e49557.10.1371/journal.pone.0049557.
94. Jin H., Meyer J.M., Mudaliar S., Jeste D.V. Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophr. Res. 2008, 100:70-85.10.1016/j.schres.2007.11.026.
95. Joëls M., Fernandez G., Roozendaal B. Stress and emotional memory: a matter of timing. Trends Cogn. Sci. 2011, 15:280-288.10.1016/j.tics.2011.04.004.
96. Kageyama K., Akimoto K., Yamagata S., Sugiyama A., Murasawa S., Watanuki Y., Tamasawa N., Suda T. Dexamethasone stimulates the expression of ghrelin and its receptor in rat hypothalamic 4B cells. Regul. Pept. 2012, 174:12-17.10.1016/j.regpep.2011.11.003.
97. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001, 50:2438-2443.
98. Kanamoto N., Akamizu T., Tagami T., Hataya Y., Moriyama K., Takaya K., Hosoda H., Kojima M., Kangawa K., Nakao K. Genomic structure and characterization of the 5'-flanking region of the human ghrelin gene. Endocrinology 2004, 145:4144-4153.10.1210/en.2003-1718.
99. Kanehisa M., Akiyoshi J., Kitaichi T., Matsushita H., Tanaka E., Kodama K., Hanada H., Isogawa K. Administration of antisense DNA for ghrelin causes an antidepressant and anxiolytic response in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:1403-1407.10.1016/j.pnpbp.2006.05.005.
100. Kaur S., Ryabinin A.E. Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. Alcohol. Clin. Exp. Res. 2010, 34:1525-1534.10.1111/j.1530-0277.2010.01237.x.
101. Kawakami A., Okada N., Rokkaku K. Leptin inhibits and ghrelin augments hypothalamic noradrenaline release after stress. Stress 2008, 11:363-369.10.1080/10253890701820257.
102. Khan M.S.I., Kaiya H., Tachibana T. Central injection of urocortin-3 but not corticotrophin-releasing hormone influences the ghrelin/GHS-R1a system of the proventriculus and brain in chicks. Domest. Anim. Endocrinol. 2014, 47:27-34.10.1016/j.domaniend.2013.12.002.
103. Kim B.-J., Sohn J.-W., Park C.-S., Hahn G.-H., Koo J., Noh Y.-D., Lee C.-S. Body weight and plasma levels of ghrelin and leptin during treatment with olanzapine. J. Korean Med. Sci. 2008, 23:685-690.10.3346/jkms.2008.23.4.685.
104. Kim D.-J., Yoon S.-J., Choi B., Kim T.-S., Woo Y.S., Kim W., Myrick H., Peterson B.S., Choi Y.B., Kim Y.-K., Jeong J. Increased fasting plasma ghrelin levels during alcohol abstinence. Alcohol Alcohol. 2005, 40:76-79.10.1093/alcalc/agh108.
105. Kindler J., Bailer U., de Zwaan M., Fuchs K., Leisch F., Grün B., Strnad A., Stojanovic M., Windisch J., Lennkh-Wolfsberg C., El-Giamal N., Sieghart W., Kasper S., Aschauer H. No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with eating disorders. Nord. J. Psychiatry 2011, 65:203-207.10.3109/08039488.2010.525258.
106. Kluge M., Gazea M., Schüssler P., Genzel L., Dresler M., Kleyer S., Uhr M., Yassouridis A., Steiger A. Ghrelin increases slow wave sleep and stage 2 sleep and decreases stage 1 sleep and REM sleep in elderly men but does not affect sleep in elderly women. Psychoneuroendocrinology 2010, 35:297-304.10.1016/j.psyneuen.2009.07.007.
107. Kluge M., Riedl S., Uhr M., Schmidt D., Zhang X., Yassouridis A., Steiger A. Ghrelin affects the hypothalamus-pituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. Eur. J. Endocrinol. 2010, 162:1059-1065.10.1530/EJE-10-0094.
108. Kluge M., Schmidt D., Uhr M., Steiger A. Ghrelin suppresses nocturnal secretion of luteinizing hormone (LH) and thyroid stimulating hormone (TSH) in patients with major depression. J. Psychiatr. Res. 2013, 47:1236-1239.10.1016/j.jpsychires.2013.05.010.
109. Kluge M., Schüssler P., Bleninger P., Kleyer S., Uhr M., Weikel J.C., Yassouridis A., Zuber V., Steiger A. Ghrelin alone or co-administered with GHRH or CRH increases non-REM sleep and decreases REM sleep in young males. Psychoneuroendocrinology 2008, 33:497-506.10.1016/j.psyneuen.2008.01.008.
110. Kluge M., Schüssler P., Dresler M., Schmidt D., Yassouridis A., Uhr M., Steiger A. Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression. J. Psychiatr. Res. 2011, 45:421-426.10.1016/j.jpsychires.2010.09.002.
111. Kluge M., Schüssler P., Schmid D., Uhr M., Kleyer S., Yassouridis A., Steiger A. Ghrelin plasma levels are not altered in major depression. Neuropsychobiology 2009, 59:199-204.10.1159/000223731.
112. Kluge M., Schüssler P., Schmidt D., Uhr M., Steiger A. Ghrelin suppresses secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in women. J. Clin. Endocrinol. Metab. 2012, 97:E448-E451.10.1210/jc.2011-2607.
113. Kluge M., Schüssler P., Uhr M., Yassouridis A., Steiger A. Ghrelin suppresses secretion of luteinizing hormone in humans. J. Clin. Endocrinol. Metab. 2007, 92:3202-3205.10.1210/jc.2007-0593.
114. Kluge M., Schüssler P., Zuber V., Kleyer S., Yassouridis A., Dresler M., Uhr M., Steiger A. Ghrelin enhances the nocturnal secretion of cortisol and growth hormone in young females without influencing sleep. Psychoneuroendocrinology 2007, 32:1079-1085.10.1016/j.psyneuen.2007.09.001.
115. Kluge M., Uhr M., Bleninger P., Yassouridis A., Steiger A. Ghrelin suppresses secretion of FSH in males. Clin. Endocrinol. (Oxf). 2009, 70:920-923.10.1111/j.1365-2265.2008.03440.x.
116. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.10.1038/45230.
117. Kojima M., Kangawa K. Ghrelin: more than endogenous growth hormone secretagogue. Ann. N. Y. Acad. Sci. 2010, 1200:140-148.10.1111/j.1749-6632.2010.05516.x.
118. Kojima S., Nakahara T., Nagai N., Muranaga T., Tanaka M., Yasuhara D., Masuda A., Date Y., Ueno H., Nakazato M., Naruo T. Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clin. Endocrinol. (Oxf). 2005, 62:74-78.10.1111/j.1365-2265.2004.02176.x.
119. Koopmann A., von der Goltz C., Grosshans M., Dinter C., Vitale M., Wiedemann K., Kiefer F. The association of the appetitive peptide acetylated ghrelin with alcohol craving in early abstinent alcohol dependent individuals. Psychoneuroendocrinology 2012, 37:980-986.10.1016/j.psyneuen.2011.11.005.
120. Kraus T., Schanze A., Gröschl M., Bayerlein K., Hillemacher T., Reulbach U., Kornhuber J., Bleich S. Ghrelin levels are increased in alcoholism. Alcohol. Clin. Exp. Res. 2005, 29:2154-2157.10.1097/01.alc.0000191753.82554.7e.
121. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.10.1038/nature07455.
122. Kristenssson E., Sundqvist M., Astin M., Kjerling M., Mattsson H., Dornonville de la Cour C., Håkanson R., Lindström E. Acute psychological stress raises plasma ghrelin in the rat. Regul. Pept. 2006, 134:114-117.10.1016/j.regpep.2006.02.003.
123. Kurt E., Guler O., Serteser M., Cansel N., Ozbulut O., Altinbaş K., Alataş G., Savaş H., Gecici O. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders. Neurosci. Lett. 2007, 426:49-53.10.1016/j.neulet.2007.08.018.
124. Lambert E., Lambert G., Ika-Sari C., Dawood T., Lee K., Chopra R., Straznicky N., Eikelis N., Drew S., Tilbrook A., Dixon J., Esler M., Schlaich M.P. Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension 2011, 58:43-50.10.1161/HYPERTENSIONAHA.111.171025.
125. Landgren S., Jerlhag E., Hallman J., Oreland L., Lissner L., Strandhagen E., Thelle D.S., Zetterberg H., Blennow K., Engel J.A. Genetic variation of the ghrelin signaling system in females with severe alcohol dependence. Alcohol. Clin. Exp. Res. 2010, 34:1519-1524.10.1111/j.1530-0277.2010.01236.x.
126. Landgren S., Jerlhag E., Zetterberg H., Gonzalez-Quintela A., Campos J., Olofsson U., Nilsson S., Blennow K., Engel J.A. Association of pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes with heavy alcohol use and body mass. Alcohol. Clin. Exp. Res. 2008, 32:2054-2061.10.1111/j.1530-0277.2008.00793.x.
127. Landgren S., Simms J.A., Hyytiä P., Engel J.A., Bartlett S.E., Jerlhag E. Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. Addict. Biol. 2012, 17:86-94.10.1111/j.1369-1600.2010.00280.x.
128. Landgren S., Simms J.A., Thelle D.S., Strandhagen E., Bartlett S.E., Engel J.A., Jerlhag E. The ghrelin signalling system is involved in the consumption of sweets. PLOS ONE 2011, 6:e18170.10.1371/journal.pone.0018170.
129. Leggio L., Addolorato G., Cippitelli A., Jerlhag E., Kampov-Polevoy A.B., Swift R.M. Role of feeding-related pathways in alcohol dependence: a focus on sweet preference, NPY, and ghrelin. Alcohol. Clin. Exp. Res. 2011, 35:194-202.10.1111/j.1530-0277.2010.01334.x.
130. Leggio L., Ferrulli A., Cardone S., Nesci A., Miceli A., Malandrino N., Capristo E., Canestrelli B., Monteleone P., Kenna G.A., Swift R.M., Addolorato G. Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving. Addict. Biol. 2012, 17:452-464.10.1111/j.1369-1600.2010.00308.x.
131. Leggio L., Zywiak W.H., Fricchione S.R., Edwards S.M., de la Monte S.M., Swift R.M., Kenna G.A. Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation. Biol. Psychiatry 2014,10.1016/j.biopsych.2014.03.019.
132. Leung P.-K., Chow K.B.S., Lau P.-N., Chu K.-M., Chan C.-B., Cheng C.H.K., Wise H. The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cell. Signal. 2007, 19:1011-1022.10.1016/j.cellsig.2006.11.011.
133. Li E., Kim Y., Kim S., Park S. Ghrelin-induced hippocampal neurogenesis and enhancement of cognitive function are mediated independently of GH/IGF-1 axis: lessons from the spontaneous dwarf rats. Endocr. J. 2013, 60:1065-1075.
134. Lockie S.H., Andrews Z.B. The hormonal signature of energy deficit: increasing the value of food reward. Mol. Metab. 2013, 2:329-336.10.1016/j.molmet.2013.08.003.
135. Lodge D.J., Grace A.A. Developmental pathology, dopamine, stress and schizophrenia. Int. J. Dev. Neurosci. 2011, 29:207-213.10.1016/j.ijdevneu.2010.08.002.
136. Lundholm K., Gunnebo L., Körner U., Iresjö B.-M., Engström C., Hyltander A., Smedh U., Bosaeus I. Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study. Cancer 2010, 116:2044-2052.10.1002/cncr.24917.
137. Lutter M., Sakata I., Osborne-Lawrence S., Rovinsky S.A., Anderson J.G., Jung S., Birnbaum S., Yanagisawa M., Elmquist J.K., Nestler E.J., Zigman J.M. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat. Neurosci. 2008, 11:752-753.10.1038/nn.2139.
138. Ma L., Zhang D., Tang Y., Lu Y., Zhang Y., Gao Y., Xia L., Zhao K., Chai L.-Y., Xiao Q. Ghrelin-attenuated cognitive dysfunction in streptozotocin-induced diabetic rats. Alzheimer Dis. Assoc. Disord. 2011, 25:352-363.10.1097/WAD.0b013e31820ce536.
139. Malik S., McGlone F., Bedrossian D., Dagger A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab. 2008, 7:400-409.10.1016/j.cmet.2008.03.007.
140. Maric T., Sedki F., Ronfard B., Chafetz D., Shalev U. A limited role for ghrelin in heroin self-administration and food deprivation-induced reinstatement of heroin seeking in rats. Addict. Biol. 2012, 17:613-622.10.1111/j.1369-1600.2011.00396.x.
141. Martins I., Gomes S., Costa R.O., Otvos L., Oliveira C.R., Resende R., Pereira C.M.F. Leptin and ghrelin prevent hippocampal dysfunction induced by Aβ oligomers. Neuroscience 2013, 241:41-51.10.1016/j.neuroscience.2013.02.062.
142. Matsuo K., Nakano M., Nakashima M., Watanuki T., Egashira K., Matsubara T., Watanabe Y. Neural correlates of plasma acylated ghrelin level in individuals with major depressive disorder. Brain Res. 2012, 1473:185-192.10.1016/j.brainres.2012.07.027.
143. McBride W.J., Li T.K. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit. Rev. Neurobiol. 1998, 12:339-369.
144. McFarlane M.R., Brown M.S., Goldstein J.L., Zhao T.-J. Induced ablation of ghrelin cells in adult mice does not decrease food intake, body weight, or response to high-fat diet. Cell Metab. 2014, 20:54-60.10.1016/j.cmet.2014.04.007.
145. Méquinion M., Langlet F., Zgheib S., Dickson S., Dehouck B., Chauveau C., Viltart O. Ghrelin: central and peripheral implications in anorexia nervosa. Front. Endocrinol. (Lausanne) 2013, 4:15.10.3389/fendo.2013.00015.
146. Meyer R.M., Burgos-Robles A., Liu E., Correia S.S., Goosens K.A. A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear. Mol. Psychiatry 2013, 1-11.10.1038/mp.2013.135.
147. Miljic D., Pekic S., Djurovic M., Doknic M., Milic N., Casanueva F.F., Ghatei M., Popovic V. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 2006, 91:1491-1495.10.1210/jc.2005-2304.
148. Misra M., Miller K.K., Herzog D.B., Ramaswamy K., Aggarwal A., Almazan C., Neubauer G., Breu J., Klibanski A. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J. Clin. Endocrinol. Metab. 2004, 89:1605-1612.10.1210/jc.2003-031861.
149. Monteleone P., Fabrazzo M., Tortorella A., Martiadis V., Serritella C., Maj M. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa. Psychoneuroendocrinology 2005, 30:243-250.10.1016/j.psyneuen.2004.07.004.
150. Monteleone P., Maj M. Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake. Psychoneuroendocrinology 2013, 38:312-330.10.1016/j.psyneuen.2012.10.021.
151. Monteleone P., Martiadis V., Fabrazzo M., Serritella C., Maj M. Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours. Psychol. Med. 2003, 33:1387-1394.
152. Monteleone P., Martiadis V., Rigamonti A.E., Fabrazzo M., Giordani C., Muller E.E., Maj M. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol. Psychiatry 2005, 57:926-931.10.1016/j.biopsych.2005.01.004.
153. Monteleone P., Serritella C., Martiadis V., Scognamiglio P., Maj M. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J. Clin. Endocrinol. Metab. 2008, 93:4418-4421.10.1210/jc.2008-1138.
154. Monteleone P., Serritella C., Scognamiglio P., Maj M. Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa. Psychoneuroendocrinology 2010, 35:284-288.10.1016/j.psyneuen.2009.07.001.
155. Monteleone P., Tortorella A., Castaldo E., Di Filippo C., Maj M. No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa. Neurosci. Lett. 2006, 398:325-327.10.1016/j.neulet.2006.01.023.
156. Monteleone P., Tortorella A., Castaldo E., Di Filippo C., Maj M. The Leu72Met polymorphism of the ghrelin gene is significantly associated with binge eating disorder. Psychiatr. Genet. 2007, 17:13-16.10.1097/YPG.0b013e328010e2c3.
157. Monteleone P., Tortorella A., Scognamiglio P., Serino I., Monteleone A.M., Maj M. The acute salivary ghrelin response to a psychosocial stress is enhanced in symptomatic patients with bulimia nervosa: a pilot study. Neuropsychobiology 2012, 66:230-236.10.1159/000341877.
158. Moon M., Cha M.-Y., Mook-Jung I. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice. J. Alzheimers Dis. 2014,10.3233/JAD-132417.
159. Moon M., Choi J.G., Nam D.W., Hong H.-S., Choi Y.-J., Oh M.S., Mook-Jung I. Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-β1-42 oligomer-injected mice. J. Alzheimers Dis. 2011, 23:147-159.10.3233/JAD-2010-101263.
160. Morganstern I., Barson J.R., Leibowitz S.F. Regulation of drug and palatable food overconsumption by similar peptide systems. Curr. Drug Abuse Rev. 2011, 4:163-173.
161. Motivala S.J., Tomiyama A.J., Ziegler M., Khandrika S., Irwin M.R. Nocturnal levels of ghrelin and leptin and sleep in chronic insomnia. Psychoneuroendocrinology 2009, 34:540-545.10.1016/j.psyneuen.2008.10.016.
162. Mozid A.M., Tringali G., Forsling M.L., Hendricks M.S., Ajodha S., Edwards R., Navarra P., Grossman A.B., Korbonits M. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm. Metab. Res. 2003, 35:455-459.10.1055/s-2003-41801.
163. Müller T.D., Tschöp M.H., Jarick I., Ehrlich S., Scherag S., Herpertz-Dahlmann B., Zipfel S., Herzog W., de Zwaan M., Burghardt R., Fleischhaker C., Klampfl K., Wewetzer C., Herpertz S., Zeeck A., Tagay S., Burgmer M., Pfluger P.T., Scherag A., Hebebrand J., Hinney A. Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosa. J. Psychiatr. Res. 2011, 45:706-711.10.1016/j.jpsychires.2010.10.001.
164. Munsch S., Biedert E., Meyer A.H., Herpertz S., Beglinger C. CCK, ghrelin, and PYY responses in individuals with binge eating disorder before and after a cognitive behavioral treatment (CBT). Physiol. Behav. 2009, 97:14-20.10.1016/j.physbeh.2009.01.015.
165. Murashita M., Kusumi I., Inoue T., Takahashi Y., Hosoda H., Kangawa K., Koyama T. Olanzapine increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology 2005, 30:106-110.10.1016/j.psyneuen.2004.05.008.
166. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., Kangawa K. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005, 128:1187-1193.10.1378/chest.128.3.1187.
167. Nakahara T., Kojima S., Tanaka M., Yasuhara D., Harada T., Sagiyama K., Muranaga T., Nagai N., Nakazato M., Nozoe S., Naruo T., Inui A. Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J. Psychiatr. Res. 2007, 41:814-820.10.1016/j.jpsychires.2006.07.021.
168. Nakashima K., Akiyoshi J., Hatano K., Hanada H., Tanaka Y., Tsuru J., Matsushita H., Kodama K., Isogawa K. Ghrelin gene polymorphism is associated with depression, but not panic disorder. Psychiatr. Genet. 2008, 18:257.10.1097/YPG.0b013e328306c979.
169. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001, 409:194-198.10.1038/35051587.
170. Natalucci G., Riedl S., Gleiss A., Zidek T., Frisch H. Spontaneous 24-h ghrelin secretion pattern in fasting subjects: maintenance of a meal-related pattern. Eur. J. Endocrinol. 2005, 152:845-850.10.1530/eje.1.01919.
171. Nedvídková J., Krykorková I., Barták V., Papezová H., Gold P.W., Alesci S., Pacak K. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 2003, 88:1678-1682.10.1210/jc.2002-021669.
172. Ochi M., Tominaga K., Tanaka F., Tanigawa T., Shiba M., Watanabe T., Fujiwara Y., Oshitani N., Higuchi K., Arakawa T. Effect of chronic stress on gastric emptying and plasma ghrelin levels in rats. Life Sci. 2008, 82:862-868.10.1016/j.lfs.2008.01.020.
173. Ogaya M., Kim J., Sasaki K. Ghrelin postsynaptically depolarizes dorsal raphe neurons in rats in vitro. Peptides 2011, 32:1606-1616.10.1016/j.peptides.2011.07.001.
174. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R.L., Heiman M.L., Lehnert P., Fichter M., Tschop M. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 2001, 145:669-673.10.1530/eje.0.1450669.
175. Otto B., Tschöp M., Frühauf E., Heldwein W., Fichter M., Otto C., Cuntz U. Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology 2005, 30:577-581.10.1016/j.psyneuen.2005.01.009.
176. Ozsoy S., Besirli A., Abdulrezzak U., Basturk M. Serum ghrelin and leptin levels in patients with depression and the effects of treatment. Psychiatry Investig. 2014, 11:167-172.10.4306/pi.2014.11.2.167.
177. Palik E., Birkás K.D., Faludi G., Karádi I., Cseh K. Correlation of serum ghrelin levels with body mass index and carbohydrate metabolism in patients treated with atypical antipsychotics. Diabetes Res. Clin. Pract. 2005, 68(Suppl. 1):S60-S64.10.1016/j.diabres.2005.03.008.
178. Palotai M., Bagosi Z., Jászberényi M., Csabafi K., Dochnal R., Manczinger M., Telegdy G., Szabó G. Ghrelin amplifies the nicotine-induced dopamine release in the rat striatum. Neurochem. Int. 2013, 63:239-243.10.1016/j.neuint.2013.06.014.
179. Panagopoulos V.N., Ralevski E. The role of ghrelin in addiction: a review. Psychopharmacology (Berl). 2014, 231:2725-2740.10.1007/s00213-014-3640-0.
180. Paslakis G., Buchmann A.F., Westphal S., Banaschewski T., Hohm E., Zimmermann U.S., Laucht M., Deuschle M. Intrauterine exposure to cigarette smoke is associated with increased ghrelin concentrations in adulthood. Neuroendocrinology 2014, 99:123-129.10.1159/000363325.
181. Paslakis G., Westphal S., Hamann B., Gilles M., Lederbogen F., Deuschle M. Unstimulated and glucose-stimulated ghrelin in depressed patients and controls. J. Psychopharmacol. 2014, 28:582-586.10.1177/0269881114527655.
182. Perello M., Sakata I., Birnbaum S., Chuang J.-C., Osborne-Lawrence S., Rovinsky S.A., Woloszyn J., Yanagisawa M., Lutter M., Zigman J.M. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol. Psychiatry 2010, 67:880-886.10.1016/j.biopsych.2009.10.030.
183. Pilc A., Wierońska J.M., Skolnick P. Glutamate-based antidepressants: preclinical psychopharmacology. Biol. Psychiatry 2013, 73:1125-1132.10.1016/j.biopsych.2013.01.021.
184. Pinar M., Gulsun M., Tasci I., Erdil A., Bolu E., Acikel C., Doruk A. Maprotiline induced weight gain in depressive disorder: changes in circulating ghrelin and adiponectin levels and insulin sensitivity. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:135-139.10.1016/j.pnpbp.2007.07.028.
185. Pinheiro A.P., Bulik C.M., Thornton L.M., Sullivan P.F., Root T.L., Bloss C.S., Berrettini W.H., Schork N.J., Kaye W.H., Bergen A.W., Magistretti P., Brandt H., Crawford S., Crow S., Fichter M.M., Goldman D., Halmi K.A., Johnson C., Kaplan A.S., Keel P.K., Klump K.L., La Via M., Mitchell J.E., Strober M., Rotondo A., Treasure J., Woodside D.B. Association study of 182 candidate genes in anorexia nervosa. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2010, 153B:1070-1080.10.1002/ajmg.b.31082.
186. Poretti M.B., Rask-Andersen M., Kumar P., Rubiales de Barioglio S., Fiol de Cuneo M., Schiöth H.B., Carlini V.P. Ghrelin effects expression of several genes associated with depression-like behavior. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014,10.1016/j.pnpbp.2014.09.012.
187. Proto C., Romualdi D., Cento R.M., Spada R.S., Di Mento G., Ferri R., Lanzone A. Plasma levels of neuropeptides in Alzheimer's disease. Gynecol. Endocrinol. 2006, 22:213-218.10.1080/09513590500519385.
188. Quarta D., Di Francesco C., Melotto S., Mangiarini L., Heidbreder C., Hedou G. Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens. Neurochem. Int. 2009, 54:89-94.10.1016/j.neuint.2008.12.006.
189. Raspopow K., Abizaid A., Matheson K., Anisman H. Psychosocial stressor effects on cortisol and ghrelin in emotional and non-emotional eaters: influence of anger and shame. Horm. Behav. 2010, 58:677-684.10.1016/j.yhbeh.2010.06.003.
190. Ribeiro L.F., Catarino T., Santos S.D., Benoist M., van Leeuwen J.F., Esteban J.A., Carvalho A.L. Ghrelin triggers the synaptic incorporation of AMPA receptors in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E149-E158.10.1073/pnas.1313798111.
191. Ross S., Peselow E. The neurobiology of addictive disorders. Clin. Neuropharmacol. 2009, 32:269-276.
192. Rouach V., Bloch M., Rosenberg N., Gilad S., Limor R., Stern N., Greenman Y. The acute ghrelin response to a psychological stress challenge does not predict the post-stress urge to eat. Psychoneuroendocrinology 2007, 693-702.10.1016/j.psyneuen.2007.04.010.
193. Sadakierska-Chudy A., Frankowska M., Filip M. Mitoepigenetics and drug addiction. Pharmacol. Ther. 2014,10.1016/j.pharmthera.2014.06.002.
194. Schaeffer M., Langlet F., Lafont C., Molino F., Hodson D.J., Roux T., Lamarque L., Verdié P., Bourrier E., Dehouck B., Banères J.-L., Martinez J., Méry P.-F., Marie J., Trinquet E., Fehrentz J.-A., Prévot V., Mollard P. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:1512-1517.10.1073/pnas.1212137110.
195. Schanze A., Reulbach U., Scheuchenzuber M., Groschl M., Kornhuber J., Kraus T. Ghrelin and eating disturbances in psychiatric disorders. Neuropsychobiology 2008, 57:126-130.10.1159/000138915.
196. Schellekens H., Finger B.C., Dinan T.G., Cryan J.F. Ghrelin signalling and obesity: at the interface of stress, mood and food reward. Pharmacol. Ther. 2012, 135:316-326.10.1016/j.pharmthera.2012.06.004.
197. Schmid D.A., Held K., Ising M., Uhr M., Weikel J.C., Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 2005, 30:1187-1192.10.1038/sj.npp.1300670.
198. Schmid D.A., Wichniak A., Uhr M., Ising M., Brunner H., Held K., Weikel J.C., Sonntag A., Steiger A. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology 2006, 31:832-844.10.1038/sj.npp.1300923.
199. Schmid S.M., Hallschmid M., Jauch-Chara K., Born J., Schultes B. A single night of sleep deprivation increases ghrelin levels and feelings of hunger in normal-weight healthy men. J. Sleep Res. 2008, 17:331-334.10.1111/j.1365-2869.2008.00662.x.
200. Schur E.A., Cummings D.E., Callahan H.S., Foster-Schubert K.E. Association of cognitive restraint with ghrelin, leptin, and insulin levels in subjects who are not weight-reduced. Physiol. Behav. 2008, 93:706-712.10.1016/j.physbeh.2007.11.025.
201. Schüssler P., Kluge M., Yassouridis A., Dresler M., Uhr M., Steiger A. Ghrelin levels increase after pictures showing food. Obesity (Silver Spring) 2012, 20:1212-1217.10.1038/oby.2011.385.
202. Schüssler P., Uhr M., Ising M., Weikel J.C., Schmid D.A., Held K., Mathias S., Steiger A. Nocturnal ghrelin, ACTH, GH and cortisol secretion after sleep deprivation in humans. Psychoneuroendocrinology 2006, 31:915-923.10.1016/j.psyneuen.2006.05.002.
203. Sedláčková D., Kopečková J., Papežová H., Vybíral S., Kvasničková H., Hill M., Nedvídková J. Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast. Physiol. Res. 2011, 60:165-173.
204. Sentissi O., Grouselle D., Viala A., Bourdel M.C., Olié J.P., Epelbaum J., Poirier M.F. Ghrelin and leptin levels in schizophrenic patients treated with antipsychotic monotherapy. J. Clin. Psychopharmacol. 2009, 29:304-306.10.1097/JCP.0b013e3181a390ed.
205. Shibata N., Ohnuma T., Kuerban B., Komatsu M., Arai H. Genetic association between ghrelin polymorphisms and Alzheimer's disease in a Japanese population. Dement. Geriatr. Cogn. Disord. 2011, 32:178-181.10.1159/000333075.
206. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., Nozoe S.-I., Hosoda H., Kangawa K., Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 2002, 87:240-244.10.1210/jcem.87.1.8129.
207. Soriano-Guillén L., Barrios V., Campos-Barros A., Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J. Pediatr. 2004, 144:36-42.10.1016/j.jpeds.2003.10.036.
208. Spencer S.J., Xu L., Clarke M.A., Lemus M., Reichenbach A., Geenen B., Kozicz T., Andrews Z.B. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biol. Psychiatry 2012, 72:457-465.10.1016/j.biopsych.2012.03.010.
209. Spiegel K., Tasali E., Penev P., Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann. Intern. Med. 2004, 141:846-850.
210. Spitznagel M.B., Benitez A., Updegraff J., Potter V., Alexander T., Glickman E., Gunstad J. Serum ghrelin is inversely associated with cognitive function in a sample of non-demented elderly. Psychiatry Clin. Neurosci. 2010, 64:608-611.10.1111/j.1440-1819.2010.02145.x.
211. Steiger A., Dresler M., Schüssler P., Kluge M. Ghrelin in mental health, sleep, memory. Mol. Cell. Endocrinol. 2011, 340:88-96.10.1016/j.mce.2011.02.013.
212. Stock S., Leichner P., Wong A.C.K., Ghatei M.A., Kieffer T.J., Bloom S.R., Chanoine J.-P. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J. Clin. Endocrinol. Metab. 2005, 90:2161-2168.10.1210/jc.2004-1251.
213. Stoyanova I.I., le Feber J., Rutten W.L.C. Ghrelin stimulates synaptic formation in cultured cortical networks in a dose-dependent manner. Regul. Pept. 2013, 186:43-48.10.1016/j.regpep.2013.07.004.
214. Suchankova P., Steensland P., Fredriksson I., Engel J.A., Jerlhag E. Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption. PLOS ONE 2013, 8:e71284.10.1371/journal.pone.0071284.
215. Szentirmai E., Hajdu I., Obal F., Krueger J.M. Ghrelin-induced sleep responses in ad libitum fed and food-restricted rats. Brain Res. 2006, 1088:131-140.10.1016/j.brainres.2006.02.072.
216. Taheri S., Lin L., Austin D., Young T., Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004, 1:e62.10.1371/journal.pmed.0010062.
217. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., Mori K., Komatsu Y., Usui T., Shimatsu A., Ogawa Y., Hosoda K., Akamizu T., Kojima M., Kangawa K., Nakao K. Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab. 2000, 85:4908-4911.10.1210/jcem.85.12.7167.
218. Tanaka K., Morinobu S., Ichimura M., Asakawa A., Inui A., Hosoda H., Kangawa K., Yamawaki S. Decreased levels of ghrelin, cortisol, and fasting blood sugar, but not n-octanoylated ghrelin, in Japanese schizophrenic inpatients treated with olanzapine. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1527-1532.10.1016/j.pnpbp.2008.05.013.
219. Tanaka M., Nakahara T., Kojima S., Nakano T., Muranaga T., Nagai N., Ueno H., Nakazato M., Nozoe S.-I., Naruo T. Effect of nutritional rehabilitation on circulating ghrelin and growth hormone levels in patients with anorexia nervosa. Regul. Pept. 2004, 122:163-168.10.1016/j.regpep.2004.06.015.
220. Tanaka M., Naruo T., Muranaga T., Yasuhara D., Shiiya T., Nakazato M., Matsukura S., Nozoe S.-I. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur. J. Endocrinol. 2002, 146:R1-R3.
221. Tanaka M., Naruo T., Yasuhara D., Tatebe Y., Nagai N., Shiiya T., Nakazato M., Matsukura S., Nozoe S. Fasting plasma ghrelin levels in subtypes of anorexia nervosa. Psychoneuroendocrinology 2003, 28:829-835.
222. Theisen F.M., Gebhardt S., Brömel T., Otto B., Heldwein W., Heinzel-Gutenbrunner M., Krieg J.-C., Remschmidt H., Tschöp M., Hebebrand J. A prospective study of serum ghrelin levels in patients treated with clozapine. J. Neural Transm. 2005, 112:1411-1416.10.1007/s00702-005-0284-6.
223. Thiele T.E., Stewart R.B., Badia-Elder N.E., Geary N., Massi M., Leibowitz S.F., Hoebel B.G., Egli M. Overlapping peptide control of alcohol self-administration and feeding. Alcohol. Clin. Exp. Res. 2004, 28:288-294.
224. Togo T., Hasegawa K., Miura S., Hosojima H., Kojima K., Shoji M., Kase A., Uchikado H., Iseki E., Kosaka K. Serum ghrelin concentrations in patients receiving olanzapine or risperidone. Psychopharmacology (Berl). 2004, 172:230-232.10.1007/s00213-003-1642-4.
225. Tolle V., Kadem M., Bluet-Pajot M.-T., Frere D., Foulon C., Bossu C., Dardennes R., Mounier C., Zizzari P., Lang F., Epelbaum J., Estour B. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J. Clin. Endocrinol. Metab. 2003, 88:109-116.10.1210/jc.2002-020645.
226. Troisi A., Di Lorenzo G., Lega I., Tesauro M., Bertoli A., Leo R., Iantorno M., Pecchioli C., Rizza S., Turriziani M., Lauro R., Siracusano A. Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology 2005, 81:259-266.10.1159/000087923.
227. Trovato L., Gallo D., Settanni F., Gesmundo I., Ghigo E., Granata R. Obestatin: is it really doing something?. Front. Horm. Res. 2014, 42:175-185.10.1159/000358346.
228. Tschöp M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.10.1038/35038090.
229. Tschöp M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50:707-709.
230. Vengeliene V. The role of ghrelin in drug and natural reward. Addict. Biol. 2013, 18:897-900.10.1111/adb.12114.
231. Walker A.K., Rivera P.D., Wang Q., Chuang J.-C., Tran S., Osborne-Lawrence S., Estill S.J., Starwalt R., Huntington P., Morlock L., Naidoo J., Williams N.S., Ready J.M., Eisch A.J., Pieper A.A., Zigman J.M. The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis. Mol. Psychiatry 2014,10.1038/mp.2014.34.
232. Weikel J.C., Wichniak A., Ising M., Brunner H., Friess E., Held K., Mathias S., Schmid D.A., Uhr M., Steiger A. Ghrelin promotes slow-wave sleep in humans. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E407-E415.10.1152/ajpendo.00184.2002.
233. Wellman P.J., Clifford P.S., Rodriguez J.A., Hughes S., Di Francesco C., Melotto S., Tessari M., Corsi M., Bifone A., Gozzi A. Brain reinforcement system function is ghrelin dependent: studies in the rat using pharmacological fMRI and intracranial self-stimulation. Addict. Biol. 2012, 17:908-919.10.1111/j.1369-1600.2011.00392.x.
234. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research 1993, World Health Organisation.
235. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A., Bloom S.R. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001, 50:2540-2547.
236. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., Kennedy A.R., Roberts G.H., Morgan D.G., Ghatei M.A., Bloom S.R. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000, 141:4325-4328.10.1210/en.141.11.4325.
237. Wysokiński A., Kowalski M., Kłoszewska I. Serum levels of desacyl ghrelin in patients with schizophrenia on clozapine monotherapy. Psychiatry Clin. Neurosci. 2014,10.1111/pcn.12199.
238. Yakabi K., Noguchi M., Ohno S., Ro S., Onouchi T., Ochiai M., Takabayashi H., Takayama K., Harada Y., Sadakane C., Hattori T. Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E72-E82.10.1152/ajpendo.00695.2010.
239. Yang J., Brown M.S., Liang G., Grishin N.V., Goldstein J.L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008, 132:387-396.10.1016/j.cell.2008.01.017.
240. Zhang J.V., Ren P.-G., Avsian-Kretchmer O., Luo C.-W., Rauch R., Klein C., Hsueh A.J.W. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310:996-999.10.1126/science.1117255.
241. Zhao Z., Liu H., Xiao K., Yu M., Cui L., Zhu Q., Zhao R., Li G.-D., Zhou Y. Ghrelin administration enhances neurogenesis but impairs spatial learning and memory in adult mice. Neuroscience 2014, 257:175-185.10.1016/j.neuroscience.2013.10.063.
242. Zigman J.M., Jones J.E., Lee C.E., Saper C.B., Elmquist J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J. Comp. Neurol. 2006, 494:528-548.10.1002/cne.20823.
243. Zimmermann U.S., Buchmann A., Steffin B., Dieterle C., Uhr M. Alcohol administration acutely inhibits ghrelin secretion in an experiment involving psychosocial stress. Addict. Biol. 2007, 12:17-21.10.1111/j.1369-1600.2006.00026.x.